Author details

Full Name

Gudrun Fleischhack

Affiliation

ORCID

Career Start Year

1994

Papers

126

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37875569	Author Correction: Multiomic neuropathology improves diagnostic accuracy in pediatric neuro-oncology.	Nat Med	2024
36928815	Multiomic neuropathology improves diagnostic accuracy in pediatric neuro-oncology.	Nat Med	2023
37878777	Perinatally diagnosed congenital craniopharyngiomas in the KRANIOPHARYNGEOM trials.		2023
37085539	3D genome mapping identifies subgroup-specific chromosome conformations and tumor-dependency genes in ependymoma.	Nat Commun	2023
36548930	Outcomes of Infants and Young Children With Relapsed Medulloblastoma After Initial Craniospinal Irradiation-Sparing Approaches: An International Cohort Study.	J Clin Oncol	2023
37172610	[Pediatric Intracranial Ependymoma - Recommendations for First-Line Treatment from the German HIT-MED study group].		2023
35158738	Local and Systemic Therapy of Recurrent Medulloblastomas in Children and Adolescents: Results of the P-HIT-REZ 2005 Study.	Cancers (Basel)	2022
36340442	Long-term outcome after management of pilocytic astrocytoma in the posterior fossa in a pediatric population.	IBRO Neuroscience Reports	2022
35923779	Prevalence of osteopathologies in a single center cohort of survivors of childhood primary brain tumor.	Frontiers in Pediatrics	2022
36497345	Proton Beam Therapy for Pediatric Tumors of the Central Nervous System-Experiences of Clinical Outcome and Feasibility from the KiProReg Study.	Cancers (Basel)	2022
35190934	Clinical and molecular characterization of isolated M1 disease in pediatric medulloblastoma: experience from the German HIT-MED studies.	J Neurooncol	2022
34964901	Evaluation of dose, volume, and outcome in children with localized, intracranial ependymoma treated with proton therapy within the prospective KiProReg Study.	Neuro Oncol	2022
35158947	The Current Landscape of Targeted Clinical Trials in Non-WNT/Non-SHH Medulloblastoma.	Cancers (Basel)	2022
35008290	Relapsed Medulloblastoma in Pre-Irradiated Patients: Current Practice for Diagnostics and Treatment.	Cancers (Basel)	2021
33879448	Cross-Species Genomics Reveals Oncogenic Dependencies in ZFTA/C11orf95 Fusion-Positive Supratentorial Ependymomas.	Cancer Discov	2021
33714975	Hepatic sinusoidal obstruction syndrome and short-term application of 6-thioguanine in pediatric acute lymphoblastic leukemia.	Leukemia	2021
33502920	Clinical Outcomes and Patient-Matched Molecular Composition of Relapsed Medulloblastoma.	J Clin Oncol	2021
33919815	Eye Tumors in Childhood as First Sign of Tumor Predisposition Syndromes: Insights from an Observational Study Conducted in Germany and Austria.	Cancers (Basel)	2021
33331885	Local and systemic therapy of recurrent ependymoma in children and adolescents: short- and long-term results of the E-HIT-REZ 2005 study.	Neuro Oncol	2021
34657224	Systemic chemotherapy of pediatric recurrent ependymomas: results from the German HIT-REZ studies.	J Neurooncol	2021
34373263	The Pediatric Precision Oncology INFORM Registry: Clinical Outcome and Benefit for Patients with Very High-Evidence Targets.	Cancer Discov	2021
32330099	Nonmetastatic Medulloblastoma of Early Childhood: Results From the Prospective Clinical Trial HIT-2000 and An Extended Validation Cohort.	J Clin Oncol	2020
31971950	Treatment of children under 4 years of age with medulloblastoma and ependymoma in the HIT2000/HIT-REZ 2005 trials: Neuropsychological outcome 5 years after treatment.	PLoS One	2020
30850560	Newly Diagnosed Metastatic Intracranial Ependymoma in Children: Frequency, Molecular Characteristics, Treatment, and Outcome in the Prospective HIT Series.	Oncologist	2019
29539639	DNA methylation-based classification of central nervous system tumours.	Nature	2018
29489754	The landscape of genomic alterations across childhood cancers.	Nature	2018
29753700	Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort.	Lancet Oncol	2018
29459099	Proton Therapy for Craniopharyngioma - An Early Report from a Single European Centre.	Clinical Oncology	2018
28168833	Childhood cancer predisposition syndromes-A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology.	Am J Med Genet A	2017
28443606	Genotype-outcome correlations in pediatric AML: the impact of a monosomal karyotype in trial AML-BFM 2004.	Leukemia	2017
27863192	Treatment of Children and Adolescents With Metastatic Medulloblastoma and Prognostic Relevance of Clinical and Biologic Parameters.	J Clin Oncol	2016
26760213	Divergent clonal selection dominates medulloblastoma at recurrence.	Nature	2016
27110286	Highlights of Children with Cancer UK's Workshop on Drug Delivery in Paediatric Brain Tumours.	Ecancermedicalscience	2016
27147083	Intraventricular etoposide safety and toxicity profile in children and young adults with refractory or recurrent malignant brain tumors.	J Neurooncol	2016
27423645	Relapse patterns and outcome after relapse in standard risk medulloblastoma: a report from the HIT-SIOP-PNET4 study.	J Neurooncol	2016
27479119	Next-generation personalised medicine for high-risk paediatric cancer patients - The INFORM pilot study.	Eur J Cancer	2016
27539613	Evidence of H3 K27M mutations in posterior fossa ependymomas.	Acta Neuropathol	2016
26278499	Strategies to improve the quality of survival for childhood brain tumour survivors.	Eur J Paediatr Neurol	2015
25869725	Additional treatment with 2-Chloro-2-Deoxyadenosine during consolidation in children with high-risk acute myeloid leukemia does not improve survival.	Leukemia	2015
26346136	Intraventricular methotrexate as part of primary therapy for children with infant and/or metastatic medulloblastoma: Feasibility, acute toxicity and evidence for efficacy.	Eur J Cancer	2015
25985446	Randomised Introduction of 2-CDA as Intensification during Consolidation for Children with High-risk AML--results from Study AML-BFM 2004.	Klin Padiatr	2015
25107886	Primary central nervous system lymphoma in children and adolescents: low relapse rate after treatment according to Non-Hodgkin-Lymphoma Berlin-Frankfurt-MÃ¼nster protocols for systemic lymphoma.	Haematologica	2014
24419520	High-dose chemotherapy (HDCT) with auto-SCT in children with atypical teratoid/rhabdoid tumors (AT/RT): a report from the European Rhabdoid Registry (EU-RHAB).	Bone Marrow Transplant	2014
24661654	Postponed is not canceled: role of craniospinal radiation therapy in the management of recurrent infant medulloblastoma--an experience from the HIT-REZ 1997 & 2005 studies.	Int J Radiat Oncol Biol Phys	2014
24791927	Prognostic significance of clinical, histopathological, and molecular characteristics of medulloblastomas in the prospective HIT2000 multicenter clinical trial cohort.	Acta Neuropathol	2014
25179451	Treatment of recurrent primitive neuroectodermal tumors (PNET) in children and adolescents with high-dose chemotherapy (HDC) and stem cell support: results of the HITREZ 97 multicentre trial.	J Neurooncol	2014
23704089	Randomized trial comparing liposomal daunorubicin with idarubicin as induction for pediatric acute myeloid leukemia: results from Study AML-BFM 2004.	Blood	2013
24231268	BET bromodomain protein inhibition is a therapeutic option for medulloblastoma.	Oncotarget	2013
23043252	Nimotuzumab treatment of malignant gliomas.	Expert Opin Biol Ther	2012
22504772	A case of disseminated tuberculosis with psoas abscess in a 12-year-old girl with sickle cell trait.	Klinische Padiatrie	2012